Loading...
OTCM
CANL
Market cap93kUSD
Jul 07, Last price  
0.00USD
1D
0.00%
1Q
0.00%
Jan 2017
-99.96%
IPO
-99.97%
Name

Cannlabs Inc

Chart & Performance

D1W1MN
OTCM:CANL chart
P/E
0.11
P/S
0.02
EPS
0.00
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
187.16%
Revenues
4m
+38.04%
14,19248,49716,161146,15084,3001,364,7601,364,7601,364,7601,364,7602,498,6582,765,2363,181,2064,391,248
Net income
869k
+21.94%
-46,682-79,734-155,319-27,775-79,031-1,584,218-1,584,218-1,584,218-1,584,218803,582520,571712,797869,171
CFO
773k
+44.85%
-14,207-30,085-12,240-56,190-50,936-1,257,271-1,257,271-1,257,271-1,257,271550,619570,733533,389772,608

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

CannLabs, Inc. provides cannabis testing laboratory services in the United States. Its testing services include potency testing, residual solvent analysis, microbiological testing, pesticide testing, heavy metals testing, nutrient analysis, terpenes analysis, shelf-life/stability studies, gene expression testing, and genotyping/phenotyping testing. The company also offers data/analytics and consulting, as well as education services. CannLabs, Inc. was incorporated in 2010 and is based in Denver, Colorado.
URL
IPO date
Jun 01, 2011
Employees
37
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT